{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:04:19Z","timestamp":1787983459182,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST111-2320-B-038-062-MY3"],"award-info":[{"award-number":["MOST111-2320-B-038-062-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.biopha.2024.117738","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T03:10:36Z","timestamp":1733886636000},"page":"117738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Interleukin-38-overexpressing adenovirus infection in dendritic cell-based treatment enhances immunotherapy for allergic asthma via inducing Foxp3+ regulatory T cells"],"prefix":"10.1016","volume":"181","author":[{"given":"Hsiao-Chi","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer-Hwa","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Yi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ling","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8667-1408","authenticated-orcid":false,"given":"Yueh-Lun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117738_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111383","article-title":"Active ingredients from Chinese medicine plants as therapeutic strategies for asthma: overview and challenges","volume":"137","author":"Wang","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.117738_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155149","article-title":"Phytochemicals as treatment for allergic asthma: therapeutic effects and mechanisms of action","volume":"122","author":"Jasemi","year":"2024","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.biopha.2024.117738_bib3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00281-019-00770-3","article-title":"Resolution of allergic asthma","volume":"41","author":"Finotto","year":"2019","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.biopha.2024.117738_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110950","article-title":"DK-1108 exerts anti-inflammatory activity against phorbol 12-myristate 13-acetate-induced inflammation and protective effect against OVA-induced allergic asthma","volume":"132","author":"Kwon","year":"2020","journal-title":"Biomed. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2024.117738_bib5","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221094","article-title":"T helper 2 cells in asthma","volume":"220","author":"Harker","year":"2023","journal-title":"J. Exp. Med"},{"issue":"9","key":"10.1016\/j.biopha.2024.117738_bib6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/17476348.2018.1505507","article-title":"The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies","volume":"12","author":"Ozdemir","year":"2018","journal-title":"Expert Rev. Respir. Med"},{"issue":"Pt B","key":"10.1016\/j.biopha.2024.117738_bib7","article-title":"The role of dendritic cells in allergic diseases","volume":"113","author":"Liu","year":"2022","journal-title":"Int Immunopharmacol."},{"issue":"21","key":"10.1016\/j.biopha.2024.117738_bib8","doi-asserted-by":"crossref","first-page":"7930","DOI":"10.3390\/ijms21217930","article-title":"Dendritic cells: critical regulators of allergic asthma","volume":"21","author":"Morianos","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117738_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116440","article-title":"Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways","volume":"174","author":"Su","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2024.117738_bib10","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.3390\/ijms24097797","article-title":"Enhancing regulatory T cells to treat inflammatory and autoimmune diseases","volume":"24","author":"Fiyouzi","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117738_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101847","article-title":"Regulatory T cells in allergic inflammation","volume":"70","author":"Benamar","year":"2023","journal-title":"Semin Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117738_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaci.2023.09.025","article-title":"Regulatory T cells in dominant immunologic tolerance","volume":"153","author":"Georgiev","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2024.117738_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155808","article-title":"Multifaceted roles of IL-38 in inflammation and cancer","volume":"151","author":"Diaz-Barreiro","year":"2022","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.biopha.2024.117738_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1684\/ecn.2022.0480","article-title":"Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders","volume":"33","author":"Haghshenas","year":"2022","journal-title":"Eur. Cytokine Netw."},{"issue":"8","key":"10.1016\/j.biopha.2024.117738_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.991","article-title":"The emerging role of IL-38 in diseases: a comprehensive review","volume":"11","author":"Chen","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.biopha.2024.117738_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154963","article-title":"Interleukin-38 is elevated in inflammatory bowel diseases and suppresses intestinal inflammation","volume":"127","author":"Xie","year":"2020","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.biopha.2024.117738_bib17","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1134\/S0026893316030134","article-title":"Production of recombinant human interleukin-38 and its inhibitory effect on the expression of proinflammatory cytokines in THP-1 cells","volume":"50","author":"Yuan","year":"2016","journal-title":"Mol. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117738_bib18","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/jcmm.14902","article-title":"Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4(+) CD25(+) regulatory T cells","volume":"24","author":"Ge","year":"2020","journal-title":"J. Cell Mol. Med"},{"issue":"3","key":"10.1016\/j.biopha.2024.117738_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-211780","article-title":"Dendritic cells should not be overlooked when studying the effect of IL-38 administration in arthritis","volume":"77","author":"Jiang","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2024.117738_bib20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41423-019-0300-7","article-title":"Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma","volume":"17","author":"Sun","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2024.117738_bib21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/gt.2010.39","article-title":"Cytokine gene-modulated dendritic cells protect against allergic airway inflammation by inducing IL-10(+)IFN-gamma(+)CD4(+) T cells","volume":"17","author":"Hsu","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2024.117738_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104296","article-title":"Current and future targeted therapies for severe asthma: managing treatment with biologics based on phenotypes and biomarkers","volume":"146","author":"Santus","year":"2019","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2024.117738_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coi.2021.03.004","article-title":"Immune responses and exacerbations in severe asthma","volume":"72","author":"Camiolo","year":"2021","journal-title":"Curr. Opin. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2024.117738_bib24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s40264-014-0226-z","article-title":"Side effects of cytokines approved for therapy","volume":"37","author":"Baldo","year":"2014","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.biopha.2024.117738_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jcmm.14741","article-title":"Interleukin-38 alleviates cardiac remodelling after myocardial infarction","volume":"24","author":"Wei","year":"2020","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2024.117738_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102210","article-title":"Viral vector vaccines","volume":"77","author":"McCann","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biopha.2024.117738_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.09.004","article-title":"Construction and application of adenoviral vectors","volume":"34","author":"Zhang","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"6","key":"10.1016\/j.biopha.2024.117738_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2144\/btn-2022-0051","article-title":"Adenovirus vector system: construction, history and therapeutic applications","volume":"73","author":"Syyam","year":"2022","journal-title":"Biotechniques"},{"issue":"2","key":"10.1016\/j.biopha.2024.117738_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis."},{"issue":"3","key":"10.1016\/j.biopha.2024.117738_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14712598.2015.993374","article-title":"Adenoviruses as gene\/vaccine delivery vectors: promises and pitfalls","volume":"15","author":"Appaiahgari","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.117738_bib31","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12967-020-02632-1","article-title":"Regulatory T cells mediated immunomodulation during asthma: a therapeutic standpoint","volume":"18","author":"Khan","year":"2020","journal-title":"J. Transl. Med"},{"issue":"2","key":"10.1016\/j.biopha.2024.117738_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.biopha.2024.117738_bib33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1084\/jem.20051166","article-title":"Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+\u2009regulatory T cells is interleukin 10 dependent","volume":"202","author":"Kearley","year":"2005","journal-title":"J. Exp. Med"},{"issue":"10","key":"10.1016\/j.biopha.2024.117738_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202249983","article-title":"T-cell subsets in allergy and tolerance induction","volume":"53","author":"Suhrkamp","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117738_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41577-022-00786-1","article-title":"Allergen immunotherapy: past, present and future","volume":"23","author":"Durham","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117738_bib36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/ACI.0000000000000693","article-title":"Tolerance mechanisms in allergen immunotherapy","volume":"20","author":"Celebi Sozener","year":"2020","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2024.117738_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.912529","article-title":"Current strategies to modulate regulatory T cell activity in allergic inflammation","volume":"13","author":"Bellinghausen","year":"2022","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117738_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.intimp.2014.05.034","article-title":"Key mediators in the immunopathogenesis of allergic asthma","volume":"23","author":"Hall","year":"2014","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.117738_bib39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.intimp.2017.03.005","article-title":"Therapeutic efficacy of a co-blockade of IL-13 and IL-25 on airway inflammation and remodeling in a mouse model of asthma","volume":"46","author":"Zhang","year":"2017","journal-title":"Int Immunopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117738_bib40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jaci.2023.06.005","article-title":"Eosinophils and tissue remodeling: relevance to airway disease","volume":"152","author":"Siddiqui","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117738_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41419-020-03283-2","article-title":"Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections","volume":"12","author":"Gao","year":"2021","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.biopha.2024.117738_bib42","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3390\/cells11071105","article-title":"The role of airway epithelial cell alarmins in asthma","volume":"11","author":"Whetstone","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2024.117738_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaci.2020.12.628","article-title":"IL-25 (IL-17E) in epithelial immunology and pathophysiology","volume":"148","author":"Borowczyk","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2024.117738_bib44","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.20070406","article-title":"IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells","volume":"204","author":"Wang","year":"2007","journal-title":"J. Exp. Med"},{"issue":"7","key":"10.1016\/j.biopha.2024.117738_bib45","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1084\/jem.20061675","article-title":"Interleukin 25 promotes the initiation of proallergic type 2 responses","volume":"204","author":"Angkasekwinai","year":"2007","journal-title":"J. Exp. Med"},{"issue":"2","key":"10.1016\/j.biopha.2024.117738_bib46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jaci.2007.06.004","article-title":"Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation","volume":"120","author":"Liu","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2024.117738_bib47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14728222.2020.1783242","article-title":"Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma","volume":"24","author":"Gauvreau","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2024.117738_bib48","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JAA.S275039","article-title":"Targeting TSLP in asthma","volume":"15","author":"Parnes","year":"2022","journal-title":"J. Asthma Allergy"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222401624X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222401624X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:02:00Z","timestamp":1787922120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222401624X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":48,"alternative-id":["S075333222401624X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117738","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-38-overexpressing adenovirus infection in dendritic cell-based treatment enhances immunotherapy for allergic asthma via inducing Foxp3+ regulatory T cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117738"}}